Evidence map›Paper›PMID 40722259›Full record

ArticleBrain sciences2025

Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson's Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose.

Ángela Solleiro Vidal, Rosa Yáñez Baña, Carmen Labandeira Guerra, Maria Icíar Cimas Hernando, Iria Cabo López, Jose Manuel Paz González, Maria Gema Alonso Losada, Diego Santos García

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ángela Solleiro VidalGrupo de Investigación en Enfermedad de Parkinson y Otros Trastornos del Movimiento, INIBIC (Instituto de Investigación Biomédica de A Coruña), 15006 A Coruña, Spain.
Rosa Yáñez BañaComplejo Hospitalario Universitario de Ourense (CHUO), 32005 Ourense, Spain.
Carmen Labandeira GuerraComplejo Hospitalario Universitario de Vigo (CHUVI), 36312 Vigo, Spain.ORCID 0000-0002-6274-5871
Maria Icíar Cimas HernandoHospital de Povisa, 36211 Vigo, Spain.
Iria Cabo LópezComplejo Hospitalario Universitario de Pontevedra (CHOP), 36071 Pontevedra, Spain.ORCID 0000-0003-2436-6499
Jose Manuel Paz GonzálezDepartment of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña, 15006 A Coruña, Spain.
Maria Gema Alonso LosadaComplejo Hospitalario Universitario de Vigo (CHUVI), 36312 Vigo, Spain.
Diego Santos GarcíaGrupo de Investigación en Enfermedad de Parkinson y Otros Trastornos del Movimiento, INIBIC (Instituto de Investigación Biomédica de A Coruña), 15006 A Coruña, Spain.ORCID 0000-0002-3126-5111

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

disease durationnon-motor symptomsParkinson’s diseasepost hoc analysisquality of lifesafinamidesex

Identifiers

PMID40722259
PMCPMC12293413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.